11.04.2013 Views

michigan hypertension core curriculum - State of Michigan

michigan hypertension core curriculum - State of Michigan

michigan hypertension core curriculum - State of Michigan

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ecently published RCT investigated the effectiveness <strong>of</strong> ward-based pharmacist interventions in<br />

reducing morbidity and hospital care among older patients. Investigators demonstrated a 16% reduction<br />

in all hospital visits and a 47% reduction in visits to the emergency department in the pharmacist<br />

intervention group. 12 A similar study in an inner city ambulatory care clinic found greater overall “taking<br />

adherence”(78.8% vs. 67.9%), “scheduling adherence”(53.1% vs. 47.2%), and “refill adherence”(109%<br />

vs. 105%) respectively in the pharmacist intervention group compared to a control group assigned to<br />

usual care. 6 The effects <strong>of</strong> the intervention dissipated in the post intervention period, highlighting the<br />

importance <strong>of</strong> continuous engagement <strong>of</strong> patients in efforts to control HTN.<br />

The responsibility for adherence is shared among the patient, provider and the health care<br />

system. When prescribing medications, providers need to consider not only pharmacologic efficacy<br />

but also simple dosing regimens and inexpensive drugs. Limits on health insurance drug benefits,<br />

expensive co-pays, and lack <strong>of</strong> drug coverage have a negative impact on patient adherence and<br />

contribute to adverse outcomes. Comparisons <strong>of</strong> outcomes in Medicare+Choice patients with capped<br />

benefits <strong>of</strong> $1000 versus unlimited drug benefits demonstrated fewer <strong>of</strong>fice visits (RR 0.97) higher<br />

rates <strong>of</strong> ER visits (RR 1.09), higher non-elective hospitalizations (RR 1.13), and increased death (RR<br />

1.22) in patients with capped benefits. 8 Furthermore, a retrospective cohort study <strong>of</strong> first-fill adherence<br />

for patients with HTN found a co-pay <strong>of</strong> less than $10 was associated with greater patient adherence<br />

than co-pays greater than $10 (87% vs. 72% respectively, p< 0.001). Referral to assistance programs,<br />

access to reliable supply systems, and encouraging non-pharmaceutical therapy (low salt diet,<br />

exercise, weight loss) can help ease the cost burden and improve adherence to prescribed therapy.<br />

A large pill burden has been shown to be a major factor contributing to poor patient adherence.<br />

Several Cochrane systematic reviews have recently evaluated the evidence for specific interventions<br />

to improve adherence to antihypertensive or lipid-lowering drugs. 13,14 The review <strong>of</strong> interventions<br />

to promote antihypertensive drug adherence included 38 studies <strong>of</strong> 58 different interventions and<br />

concluded that strong evidence supports the value <strong>of</strong> reducing the number <strong>of</strong> daily doses. 13 Pill burden<br />

reduction can be achieved not only by limiting the total number <strong>of</strong> antihypertensive drugs but also by<br />

favoring usage <strong>of</strong> once-daily formulations over twice-daily and three times daily formulations. Keeping<br />

care simple by using once-daily drugs and using the fewest drugs needed to achieve blood pressure<br />

goal is central to improving patient adherence. The use <strong>of</strong> combination agents is a good strategy to<br />

reduce pill burden. However, many combination medications are relatively new and newer agents tend<br />

212 Hypertension Core Curriculum

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!